As of Apr 24
| -0.13 / -7.47%|
The 2 analysts offering 12-month price forecasts for Apricus Biosciences Inc have a median target of 4.90, with a high estimate of 5.80 and a low estimate of 4.00. The median estimate represents a +204.35% increase from the last price of 1.61.
The current consensus among 2 polled investment analysts is to Buy stock in Apricus Biosciences Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.